Form 8-K - Current report:
SEC Accession No. 0001193125-21-326009
Filing Date
2021-11-10
Accepted
2021-11-10 16:16:05
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d255851d8k.htm   iXBRL 8-K 24412
2 EX-99.1 d255851dex991.htm EX-99.1 71089
6 GRAPHIC g255851g1111002446867.jpg GRAPHIC 2696
  Complete submission text file 0001193125-21-326009.txt   230604

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA slno-20211110.xsd EX-101.SCH 2890
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE slno-20211110_lab.xml EX-101.LAB 18140
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slno-20211110_pre.xml EX-101.PRE 11407
7 EXTRACTED XBRL INSTANCE DOCUMENT d255851d8k_htm.xml XML 3405
Mailing Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065
Business Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Filer) CIK: 0001484565 (see all company filings)

IRS No.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36593 | Film No.: 211396827
SIC: 3845 Electromedical & Electrotherapeutic Apparatus